[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 18, Issue 3 (Autumn 2021) ::
Sci J Iran Blood Transfus Organ 2021, 18(3): 187-195 Back to browse issues page
Evaluation of alloantibodies in thalassemia patients referred to Hamadan Besat hospital in 2019
M. Afshari, F. Amiri , M.R. Seyedi, M. Biglari, H. Jambozorg
Abstract:   (176 Views)
Abstract
Background and Objectives
Chronic blood transfusion can cause alloimmunization in patients with thalassemia. Estimating the frequency of alloimmunization in thalassemia patients can lead to the recognition of existing limitations and the development of appropriate strategies to prevent alloimmunization in thalassemia patients. In this study, we evaluated the prevalence of alloimmunization among patients of thalassemia.
 
Materials and Methods
In this cross-sectional and retrospective study, the study population was 92 patients with thalassemia referred to Besat Hospital in Hamadan in 2019. The data of all thalassemia patients was collected by census method and entered into SPSS software version 16. The Data was analyzed using Logestic Regression and significance level by p < 0.05.
 
Results
92 patients including 54 male (58.7% ) and 38 female (41.3%), aged 2-50 years were studied. Among 92 patients, 7 people (7.6%) had positive antibody screening results. The most prevalent detected alloantibodies were anti-c with 6 patients (33.3%), anti-e with 3 patients (16.6%) and anti-JKa with 3 patients (16.6%). The meaningful relation was observed between alloimmunization and hemoglobin concentration (p = 0.006), and alloimmunization and number of blood transfusion (p= 0.009). But there was no significant relation between alloimmunization and age.
 
Conclusions 
According to the results of this study, anti-c, anti-e, and anti-JKa are the most prevalent alloantibodies in the thalassemia patients in Hamadan. This point could be useful to provide suitable matched blood units for thalassemia patients.
Keywords: Thalassemia, Blood Transfusion, Screening
Full-Text [PDF 478 kb]   (67 Downloads) |   |   Full-Text (HTML)  (64 Views)  
Type of Study: Research | Subject: Blood Transfusion
Published: 2021/10/2
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Afshari M, Amiri F, Seyedi M, Biglari M, Jambozorg H. Evaluation of alloantibodies in thalassemia patients referred to Hamadan Besat hospital in 2019. Sci J Iran Blood Transfus Organ. 2021; 18 (3) :187-195
URL: http://bloodjournal.ir/article-1-1400-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 3 (Autumn 2021) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.06 seconds with 31 queries by YEKTAWEB 4343